Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy
Nezam H. Afdhal(Beth Israel Deaconess Medical Center), Dickens Theodore, Sorin Rugină, И. Г. Бакулин(Central Research Institute of Epidemiology), Ghias-Un-Nabi Tayyab(Post Graduate Medical Institute), Sandra Y. Vasey(GlaxoSmithKline (United States)), Kwang‐Hyub Han(Yonsei University), Fred Poordad(The University of Texas at San Antonio Health Science Center), Geoffrey Dusheiko(University of the Witwatersrand), M. Rodríguez‐Torres(Puerto Rico Community Foundation), Pei‐Jer Chen(National Taiwan University), Yasser Mostafa Kamel(Daiichi Sankyo (United States)), Rita Patwardhan, Eric Lawitz(The University of Texas at San Antonio Health Science Center), James Geib(Idera Pharmaceuticals (United States)), Fiona Campbell(University of Birmingham), Aftab Mohsin(Services Institute of Medical Sciences), Mitchell L. Shiffman(Bon Secours Health System), Andrés Brainsky, Edoardo G. Giannini(Ospedale Policlinico San Martino)
Cited by 143
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k